STOCK TITAN

Acurx Pharmaceuticals, Inc. (ACXP) Total Assets by Year

ACXP

Acurx Pharmaceuticals, Inc. closed fiscal year 2025 with $7.7M in total assets, $2.4M in total liabilities and $5.3M in shareholder equity. This represents an increase of 99.3% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Acurx Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Total Assets $7.7M
Total Liabilities $2.4M
Total Equity $5.3M
YoY +99.3%
5Y CAGR +19.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ACXP Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Total Assets$7.7M+99.3%$3.9M-50.0%$7.7M-17.8%$9.4M-29.3%$13.3M+311.1%$3.2M
Total Liabilities$2.4M-25.3%$3.2M+6.6%$3.0M+47.6%$2.1M+144.3%$844K+61.5%$522K
Total Equity$5.3M+756.5%$615K-86.8%$4.7M-36.2%$7.3M-41.1%$12.4M+359.4%$2.7M

ACXP Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Total Assets$11.0M+78.4%$9.5M+98.5%$7.7M+99.3%$6.1M+2.0%$6.2M-6.4%$4.8M-47.2%$3.9M-50.0%$6.0M-16.4%$6.6M-28.8%$9.1M+23.3%$7.7M-17.8%$7.2M-34.6%
Total Liabilities$2.8M+9.3%$2.5M+1.3%$2.4M-25.3%$2.5M-25.6%$2.6M-17.8%$2.5M-19.8%$3.2M+6.6%$3.3M+3.0%$3.2M+4.4%$3.1M+50.0%$3.0M+47.6%$3.2M+172.7%
Total Equity$8.2M+128.6%$7.0M+203.4%$5.3M+756.5%$3.6M+36.5%$3.6M+4.1%$2.3M-61.5%$615K-86.8%$2.7M-32.3%$3.4M-44.9%$6.0M+12.9%$4.7M-36.2%$3.9M-59.7%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Acurx Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Acurx Pharmaceuticals, Inc.'s total assets in fiscal year 2025?

Acurx Pharmaceuticals, Inc. closed fiscal year 2025 with $7.7M in total assets, $2.4M in total liabilities and $5.3M in shareholder equity.

How fast is Acurx Pharmaceuticals, Inc.'s total assets growing?

Acurx Pharmaceuticals, Inc. (ACXP) total assets rose by 99.3% year over year, from $3.9M to $7.7M in fiscal year 2025.

How has Acurx Pharmaceuticals, Inc.'s total assets changed over the years?

Across the 6 fiscal years this page covers, Acurx Pharmaceuticals, Inc. (ACXP) total assets went from $3.2M in fiscal year 2020 to $7.7M in fiscal year 2025.

Acurx Pharmaceuticals, Inc. (ACXP) reported $11.0M in total assets in Q2 2026. This represents an increase of 78.4% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Acurx Pharmaceuticals, Inc. (ACXP) reported on that line in every period on record.